NCT03854110 2025-09-11Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With GemcitabineGeistlich Pharma AGPhase 1 Active not recruiting64 enrolled
NCT02231723 2023-11-18A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic CancerSumitomo Pharma America, Inc.Phase 1 Completed139 enrolled